Articles

  • 1 week ago | howardwolinsky.substack.com | Howard Wolinsky

    By Howard WolinskyThere’s a new sheriff in D.C., and research funding on prostate cancer along with other cancers and diseases has taken a hit already with more to come. This time a rare federally funded study on Active Surveillance (AS), is in the crosshairs. Since 2023, I have worked with the U.S. Centers for Disease Control in developing a study on Active Surveillance with an emphasis on including minority men.

  • 1 week ago | howardwolinsky.substack.com | Howard Wolinsky

    By Howard WolinskyA new study on prostate cancer presented at the American Urological Association annual meeting this week shows a dramatic decline in the past 15 years of men with low-risk prostate cancer opting for radical prostatectomies.

  • 2 weeks ago | howardwolinsky.substack.com | Howard Wolinsky

    By Howard WolinskyA new generation of urologists is revolutionizing prostate cancer care, bringing innovative approaches to improve the experience of Active Surveillance (AS) patients with low-risk prostate cancer. These advancements in prostate cancer management promise better patient outcomes and enhanced quality of life. How about eliminating gadolinium contrast and its risks for crossing the blood-brain barrier?

  • 2 weeks ago | medscape.com | Howard Wolinsky

    How many urologists are women? Ask a urologist, and you’ll get one answer. Ask artificial intelligence (AI) to draw you a picture, however, and the number will be much lower — zero, in fact, according to a new study.

  • 2 weeks ago | medscape.com | Howard Wolinsky

    A postmarketing study showed that the Optilume BPH system improved the flow of urine while leaving sexual function unchanged in men with benign prostatic hyperplasia (BPH), researchers reported at the American Urological Association 2025 Annual Meeting. in 2023, the Optilume BPH devices uses balloons to dilate the anterior commissure of the prostate, which connects the two lobes of the gland, and the roof of the prostatic urethra.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
809
Tweets
2K
DMs Open
No
Howard Wolinsky
Howard Wolinsky @journotwit
4 Oct 23

See what DrCoop says on renaming GG1: https://t.co/cyIzOkVSH8 https://t.co/VIj3hrN0rE

Howard Wolinsky
Howard Wolinsky @journotwit
6 Sep 23

RT @journotwit: Colin McFarlane, British actor of ‘Dark Knight’ fame, diagnosed with low-risk prostate cancer, taking on high-profile role…

Howard Wolinsky
Howard Wolinsky @journotwit
6 Sep 23

Check out Colin McFarlane--Commisioner Loeb in the Dark Knight--and his campaign to get out the word of prostate cancer, including active surveyillance. Brave man. https://t.co/9CfHWBxYUB